The study of Internal medicine is intertwined with the study of Fibrinogen in a number of ways. His work blends Fibrinogen and Coagulation studies together. His Coagulation study frequently draws connections to adjacent fields such as Clotting time. His work on Clotting time is being expanded to include thematically relevant topics such as Internal medicine. In his research, Barry R. O'Keefe performs multidisciplinary study on Anesthesia and Surgery. Surgery and Anesthesia are two areas of study in which Barry R. O'Keefe engages in interdisciplinary research. His Immunology research extends to the thematically linked field of Partial thromboplastin time. His Partial thromboplastin time research extends to Immunology, which is thematically connected. His study on Genetics is mostly dedicated to connecting different topics, such as Umbilical cord.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.
M R Boyd;K R Gustafson;J B McMahon;R H Shoemaker.
Antimicrobial Agents and Chemotherapy (1997)
Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.
Toshiyuki Mori;Barry R. O'Keefe;Raymond C. Sowder;Scott Bringans.
Journal of Biological Chemistry (2005)
Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions.
Eddie W Adams;Daniel M Ratner;Heidi R Bokesch;James B McMahon.
Chemistry & Biology (2004)
Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
Barry R. O'Keefe;Barbara Giomarelli;Dale L. Barnard;Shilpa R. Shenoy.
Journal of Virology (2010)
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
Barry R. O'Keefe;Fakhrieh Vojdani;Viviana Buffa;Robin J. Shattock.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Probing Protein–Carbohydrate Interactions with Microarrays of Synthetic Oligosaccharides
Daniel M. Ratner;Eddie W. Adams;Jing Su;Barry R. O'Keefe.
A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium Scytonema varium†
Heidi R. Bokesch;Barry R. O'keefe;Tawnya C. Mckee;Lewis K. Pannell.
Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.
Istvan Botos;Barry R. O’Keefe;Shilpa R. Shenoy;Laura K. Cartner.
Journal of Biological Chemistry (2002)
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus☆
Laura G. Barrientos;Barry R. O’Keefe;Mike Bray;Anthony Sanchez.
Antiviral Research (2003)
Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner.
Anders J. Bolmstedt;Barry R. O'Keefe;Shilpa R. Shenoy;James B. McMahon.
Molecular Pharmacology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: